Genetic Mutation Linked to Severe Paralysis After Mild Infections in Children

Research has uncovered a genetic mutation in the RCC1 gene that causes severe nerve damage and paralysis in children following mild infections, offering new hope for diagnosis and treatment.
Scientists at the University of Manchester have identified a genetic condition that causes children to develop severe nerve damage and paralysis following mild infections. Their research revealed that mutations in the RCC1 gene are responsible for this unusual and devastating response. The study, titled "Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants," analyzed cases from multiple countries, including the UK, Turkey, Czechia, Germany, Iran, India, Saudi Arabia, Cyprus, and Slovakia. Among the cases studied, children experienced rapid nerve deterioration after infections such as flu or respiratory illnesses, which are typically mild. For example, Timothy Bingham, who first lost the ability to walk at age two after a flu, and an 8-month-old girl who required ventilator support after a chest infection, exemplify this condition. The research team conducted laboratory experiments on patient skin cells and genetically engineered fruit flies, demonstrating that chemical damage observed in nerve cells resembles conditions like motor neuron disease and Guillain-Barré syndrome. These findings not only elucidate the genetic cause behind these severe nerve reactions but also open avenues for early diagnosis and potential treatments. The discovery offers hope for at-risk children, suggesting that interventions could be implemented before nerve damage occurs. Experts emphasize that understanding this genetic link may also provide insights into more common nerve disorders, helping to develop targeted therapies. The study underscores the importance of genetic testing in children presenting with unexplained nerve weakness after mild infections and marks a significant step toward managing rare neurodegenerative conditions in pediatric populations.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Advancements in Diagnostic Tools for Adult ADHD Detection
Research at the University of Oslo is advancing diagnostic tools to better detect ADHD in adults by studying mind wandering and brain activity patterns, aiming to improve diagnosis and treatment options.
New Molecular Testing Reveals Advances in Brain Cancer in Adolescents and Young Adults
Molecular testing is revolutionizing brain cancer diagnosis and treatment strategies in adolescents and young adults by uncovering genetic profiles that inform early and targeted interventions.
Insurance Status Significantly Influences Survival Rates in Cancer Immunotherapy
Emerging research shows that access to health insurance significantly affects survival rates in cancer patients receiving immunotherapy, emphasizing the need for expanded coverage to reduce disparities in treatment outcomes.
FDA Approves Monjuvi (Tafasitamab) for Advanced Follicular Lymphoma Treatment
The FDA has approved Monjuvi (tafasitamab) combined with rituximab and lenalidomide for adults with relapsed or refractory follicular lymphoma, offering new hope in chronic lymphoma management.



